Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Telara Pharma logo — Bringing cilastatin to clinical trials for the treatment of...

Telara Pharma

Bringing cilastatin to clinical trials for the treatment of inflammatory disorders

Founded 2020 Spain Spain 5 employees Seed Total: $100.00K Pharmaceutical

General Information

Company Name Telara Pharma
Founded Year 2020
Location Spain Spain +1
Employees 5
Industries Pharmaceutical
Funding Stage Seed
Social

Get notified when Telara Pharma moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Telara Pharma

Telara Pharma is a pharmaceutical startup founded in 2020 with a mission to revolutionize kidney disease treatment. Inspired by the pioneering work of the late Dr. Alberto Tejedor Jorge, the company focuses on developing innovative therapeutic approaches for acute kidney injury caused by toxins, sepsis, and acute kidney failure related to sepsis. The recent €100.00K Seed Round investment from GENESIS Biomed on 11 May 2021 underscores the industry's confidence in Telara Pharma's potential. The startup's commitment to addressing unmet medical needs and continuing Dr. Jorge's legacy positions it as a promising player in the pharmaceutical industry. With its strong focus on innovation and nephroprotection, Telara Pharma is poised to make a significant impact in the field of kidney disease treatment.

Taxonomy: biopharmaceutical, acute kidney injury, nephroprotection, drug development, toxicity, sepsis, renal disease, medical research, drug discovery, renal therapeutics, Gregorio Marañón Health Research Institute, Alberto Tejedor Jorge, medical innovation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 1
Investor
11 May 2021

Telara Pharma Alternatives & Competitors

Telara Pharma vs
Eliaz Therapeutics Inc
Eliaz Therapeutics Inc United States

A Therapeutic Intervention For Life-Threatening Diseases With No Effective Current Treatments

Grant
7 employees
Biotechnology, Health Care
Telara Pharma vs
NephRx Corporation
NephRx Corporation

Pioneering treatments for kidney failure, renal disorders, and gastrointestinal diseases.

Series Unknown
1 employees
Biotechnology, Health Care
Telara Pharma vs
RenalSense
RenalSense Israel

Realtime Renal Diagnostics

Series A
11 employees
Biotechnology, Health Care

FAQ About Telara Pharma

Bringing cilastatin to clinical trials for the treatment of inflammatory disorders
Telara Pharma was founded in 2020.
Telara Pharma is headquartered in Spain.
Telara Pharma operates in the following industries: Pharmaceutical.
Telara Pharma has approximately 5 employees.
Telara Pharma has completed 1 funding round, raising a total of $100.00K. The latest funding stage is Seed.
Top alternatives and competitors to Telara Pharma include Eliaz Therapeutics Inc, NephRx Corporation, RenalSense, Precise Research Centers, Arch Biopartners Inc (ARCH:TSXV) (ACHFF:OTCQB). These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Telara Pharma and Eliaz Therapeutics Inc are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Telara Pharma and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy